Stay updated on BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial
Sign up to get notified when there's something new on the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page.

Latest updates to the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page
- CheckyesterdayChange DetectedMinor site version update from v3.4.0 to v3.4.1 with no visible changes to the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new metadata revision tag 'Revision: v3.3.4' was added and the previous tag 'Revision: v3.3.3' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedThe footer now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed.SummaryDifference0.0%

- Check81 days agoChange DetectedRemoved the government funding/operating-status notice from the page.SummaryDifference0.3%

- Check102 days agoChange DetectedAdded Cali, Colombia as a study site and removed Santiago de Cali, Colombia from the locations. This updates the study's site list and may affect participant access and logistics.SummaryDifference0.4%

Stay in the know with updates to BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCD-020 Safety & Efficacy in Indolent NHL Clinical Trial page.